Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Lanza

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Minerva Medica|September 21, 2020
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemiaFrancesco Lanza, Enrico Maffini, Francesco Saraceni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 9, 2007
Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndromeAntonio Coppola, Ciro De Simone, Nicola Macarone Palmieri, et al.
Annals of Hematology|June 15, 2012
Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disordersDiana Campioni, M Antonella Bardi, Francesco Cavazzini, et al.
Haematologica|June 17, 2008
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosisDiana Campioni, Andrea Lo Monaco, Francesco Lanza, et al.
Haematologica|June 13, 2012
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 statusGiorgio Zauli, Claudio Celeghini, Elisabetta Melloni, et al.
Expert Opinion on Biological Therapy|September 6, 2012
Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patientsMassimo Martino, Alberto Bottini, Giovanni Rosti, et al.
Progress in Retinal and Eye Research|September 22, 2018
New concepts in the diagnosis and management of choroidal metastasesThibaud Mathis, Pauline Jardel, Olivier Loria, et al.
Cells|December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Space Science Reviews|March 23, 2026
Upper Atmosphere Dynamics and Drivers of Volatiles Loss from Terrestrial-Type (Exo)PlanetsDaria Kubyshkina, M J Way, Iannis Dandouras, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignanciesMelissa Dabusti, Francesco Lanza, Diana Campioni, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Minerva Medica|September 21, 2020
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemiaFrancesco Lanza, Enrico Maffini, Francesco Saraceni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 9, 2007
Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndromeAntonio Coppola, Ciro De Simone, Nicola Macarone Palmieri, et al.
Annals of Hematology|June 15, 2012
Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disordersDiana Campioni, M Antonella Bardi, Francesco Cavazzini, et al.
Haematologica|June 17, 2008
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosisDiana Campioni, Andrea Lo Monaco, Francesco Lanza, et al.
Haematologica|June 13, 2012
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 statusGiorgio Zauli, Claudio Celeghini, Elisabetta Melloni, et al.
Expert Opinion on Biological Therapy|September 6, 2012
Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patientsMassimo Martino, Alberto Bottini, Giovanni Rosti, et al.
Progress in Retinal and Eye Research|September 22, 2018
New concepts in the diagnosis and management of choroidal metastasesThibaud Mathis, Pauline Jardel, Olivier Loria, et al.
Cells|December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Space Science Reviews|March 23, 2026
Upper Atmosphere Dynamics and Drivers of Volatiles Loss from Terrestrial-Type (Exo)PlanetsDaria Kubyshkina, M J Way, Iannis Dandouras, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignanciesMelissa Dabusti, Francesco Lanza, Diana Campioni, et al.
Pageof 17